Brief: Organogenesis Holdings Q3 Revenue Rises 57% To $100.8 Mln
Nov 9 (Reuters) - Organogenesis Holdings Inc ORGO.O :
* . REPORTS THIRD QUARTER AND NINE MONTHS 2020 FINANCIAL
RESULTS
* Q3 EARNINGS PER SHARE $0.19
* Q3 REVENUE ROSE 57 PERCENT TO $100.8 MILLION
* SEES FY 2020 REVENUE $311 MILLION TO $314 MILLION
* Q3 REVENUE ESTIMATE $72 MILLION -- REFINITIV IBES DATA
* Q3 EARNINGS PER SHARE ESTIMATE $-0.08 -- REFINITIV IBES
DATA
* ORGANOGENESIS HOLDINGS -EXPECTS TO REPORT POSITIVE GAAP
NET
INCOME AND POSITIVE ADJUSTED EBITDA FOR 3 MONTHS ENDED DEC 31
Source text for Eikon: ID:nGNX4jR7x7
Further company coverage: ORGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers